# Guardant Health
Who / What
Guardant Health, Inc. is an American biotechnology company specializing in precision oncology diagnostics and digital therapeutics. The firm focuses on developing tests to detect cancer at early stages and personalized treatment solutions using advanced genomic data.
---
Background & History
Founded in 2013 by Helmy Eltoukhy and AmirAli Talasaz, Guardant Health emerged as a response to the need for more accurate and accessible cancer detection methods. The company’s origins trace back to its co-founders’ prior work in genomics and medical diagnostics, which laid the groundwork for its innovative approach. Early milestones included securing significant funding rounds and establishing partnerships with leading healthcare institutions. By 2015, Guardant Health launched its first commercial product, the **Guardant360 CDx**, a blood-based test designed to detect cancer recurrence in patients undergoing treatment.
---
Why Notable
Guardant Health is notable for pioneering liquid biopsy technology—a non-invasive method of detecting cancer through circulating tumor DNA (ctDNA) in blood samples. Its work has significantly advanced early cancer detection, reducing reliance on invasive procedures like biopsies. The company’s CDx products are FDA-approved and widely adopted by oncologists globally, making it a key player in the precision medicine sector. Additionally, Guardant Health’s focus on digital therapeutics and AI-driven diagnostics positions it at the forefront of integrating technology into oncology care.
---
In the News
As of recent reports, Guardant Health continues to expand its market presence through strategic acquisitions (e.g., **Guardant Oncology**) and partnerships with pharmaceutical companies. The company has faced regulatory scrutiny over its approval processes but remains a critical innovator in cancer diagnostics. Its growth is driven by increasing demand for non-invasive cancer screening and the rising adoption of liquid biopsy technologies across oncology.
---
Key Facts
---
